attia glp 1 Ozempic & other GLP-1 receptor agnonists: the societal impact & controversy of their growing usage Could GLP-1s impact aging and

Name: attia glp 1 Ozempic & other GLP-1 receptor agnonists: the societal impact & controversy of their growing usage Could GLP-1s impact aging and
Brand: avramcheva.com
SKU: 35095720271
Price: 27.55 USD
Availability: InStock
Rating: 4.1746 (18 reviews)

SKU: 35095720271

4.2

USD27.55 USD50.55

Pay in 4 interest-free payments of $6.89 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Could GLP 1s impact aging and cognitive health? Peter Attia, M.D. This clip is from episode # 370 of The Drive which was released on 10 27 25. In the full episode, I cover Emerging Frontiers in GLP 1 Therapeutics: A Comprehensive Evidence Base (2025) PMC GLP 1 Agonists For Obesity In Non Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Current Perspectives on GLP 1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation Current Atherosclerosis Reports Springer Nature Link Could GLP 1s Impact Aging and Cognitive Health? Peter Attia, M.D.

Store: avramcheva.com · Domain: avramcheva.com

Description

[cited 2026 Feb 11];6

Long-term administration often leads to drug tolerance and opportunistic infections (280)

This extremely limited study provided preliminary safety data but offers virtually no information about efficacy or optimal dosing

It is not a therapeutic good and has not been approved by the Therapeutic Goods Administration (TGA) for any clinical or human use

a statistically significantly higher duration of base rigidity was observed with sildenafil and IN PT-141 multiple agent therapy compared to sildenafil and IN placebo spray, or compared to placebo and IN PT-141